Ozempic patient blinded by NAION sues Novo Nordisk

A Maryland man who has lost his vision due to non-arteritic anterior ischaemic optic neuropathy (NAION) is suing Novo Nordisk, alleging that Ozempic, which he was taking for diabetes, is the cause of his condition.

Lawyers for Todd Engel, 62, filed suit yesterday in New Jersey superior court. According to the complaint, Engel is now legally blind. As a result he was forced to resign from his job and has lost the ability to drive. He was prescribed Ozempic around August 2023 and diagnosed with NAION in December of 2023.

“We see this as a very important case,” Ashley Hornstein, a lawyer for…